This is big! Worked with great statisticians on guidelines for meta-analysis & systematic review. We discuss rationales for systematic review, evaluation & interpretation of heterogeneity, & common errors in network meta-analysis, funnel plots etc.

🚨 New #JACCCardioOnc Special Issue! Dive into the bidirectional links between cancer & #CVD and their impact on research & patient care in this special focus issue: https://t.co/uIEHxhrvcW #CardioOnc @DrBonnieKy

In UKBB pts w/ cancer, expanded CHIP+ was associated with ↑incident CVD and overall dth. Additive risks seen for CHIP and mos chr alterations co-occurrence for ovr mortality. Notable CHIP-CV outcomes were cancer-specific (P int >0.05). https://t.co/Pdmm8hPEzr @ESMO_Open #CHIP

It’s on! Come check out our poster at board 346!

🥗 Powerful diet-focused study at #ASCO25 presented by @SaraKCharMD from CALGB/SWOG 80702: 🔹 Proinflammatory diet linked to worse OS in stage III colon cancer 🔹 Best outcomes in patients with high physical activity and anti-inflammatory diet 🔹 NSAIDs didn’t alter the

🏔️ A standing ovation at #ASCO25 for Dr. Christopher Booth and the CHALLENGE (CO.21) trial. A 3-year structured exercise program post-chemo in stage II/III colon cancer: ✅ Improved OS (HR 0.63, p=0.022) ✅ 1 life saved for every 14 patients 💬 “Exercise is no longer just a QOL

Fantastic presentation by @ReneeSaliby discussing our work evaluating MAdCAM-1, a circulating surrogate of gut dysbiosis, as a biomarker in patients with mRCC! #ASCO25 @ASCO @DrChoueiri @CarolinaAlvesC5 @OncoAlert

Heading to #ASCO? Jump into this event—the headband alone is worth it! ⚽️🎉

We are looking for an associate research scientist and lab manager for our translational cancer immunology lab at Yale. Please email (david.braun@yale.edu) or DM me to apply. Full information about the job and the requirements can be found here: https://t.co/we6CyXRdED Pls RT!

Abstracts Open for #KCRS25 Submit your research to the 2025 Kidney Cancer Research Summit at: https://t.co/FNMfNpr5EO… @kidneycan @IKCCorg @DrChoueiri @HHammersMD @DrRanaMcKay @montypal @arihakimi

Kidney ca is a top 10 cancer in the US, with rising incidence now in younger ppl. Previous underfunding left many feeling isolated. Dedicated funding fuels research and fosters hope. A 57% @CDMRP cut undermines our progress. Please consider what's lost by slashing this support.

The first of many: personalized neoantigen vaccines shown to be a promising effective adjuvant therapy in patients with high-risk RCC. Bravo to scientist extraordinaire @BraunMDPhD, senior author super-mentor @DrChoueiri, and all investigators for this incredible work.

Honored to receive a @ConquerCancerFd Merit Award for our work @ASCO #GU25! Very grateful for the unwavering support of my mentors and colleagues! @DrChoueiri @VincentWenxinXu @ReneeSaliby

Wishing you all that the zodiac sign of the snake symbolizes: wisdom, intuition, transformation, and resilience. Happy Lunar Year to those who celebrate! 🧧🎊

1/5 Thrilled to share in @NatureComms the clinical outcomes and scRNA-seq correlatives our phase I triplet immunotherapy (IO + IO + TKI) trial in clear cell #kidney cancer: https://t.co/h6E3ahtgX3

1/ 🧵Excited to share our latest study published in @NatureCancer co-led with amazing co-first authors and friends @TJammihal and @ChrisLabaki under the exceptional mentorship of @DrChoueiri @BraunMDPhD @ShuklaSachet https://t.co/NdJKtFjEJL

Thrilled to be a part of the Leena Peltonen School of Human Genomics this year -- an opportunity for PhD students to learn and interact 1:1 with many experts (and genuinely nice people) in the field! Apply by March 7th. Program runs July 27-31 at the Wellcome Genome Campus, UK.

"The more grateful I am, the more beauty I see." -Mary Davis. Wishing everyone a happy Thanksgiving! 🦃🍗

Excellence in kindness! Congrats to @BraunMDPhD 🥳

🚨 New Paper Alert! 🚨 Excited to share our latest review on 1st and 2nd -line treatments in mRCC in @EUplatinum , co-authored by @reneesaliby, @eddy_saad, @maxinesun, and @drchoueiri among many of the leading experts in the fields. Check it out! https://t.co/HrQKO3wcI8 (0/10)